CA
CHI Advisors LLC
Sector-focusedLong-term holderQuality / disciplined sizing
Total reported value
$252.3M
Reporting period: 2023-09-30 · Number of holdings: 28
CHI Advisors LLC disclosed 28 holdings in its latest 13F filing for the period ending 2023-09-30, with total reported value of $252.3M and a quarterly turnover rate of 0.0%.
Personality snowflake
- Concentration
- 40.42
- Portfolio Stability
- 0
- Momentum/Contrarian
- 50
- Sector conviction
- 100
- Diversification
- 52
- Sizing Uniformity
- 86.99
Recent moves
No holding changes this quarter
Holdings Map
New buyAddUnchangedTrim
Top 10 holdings by weight
Full holdings list this quarter
Showing top 26 holdings (of 28 total)
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | PLRX | Pliant Therapeutics INC | Stock-Other | 20.74% | — | -2.94% | |
| 2 | RPTX | Repare Therapeutics INC | Stock-Other | 14.27% | — | +0.60% | |
| 3 | CGEM | Cullinan Therapeutics INC | Stock-Other | 12.25% | — | — | |
| 4 | ✓ | Acelyrin INC | Stock-Other | 9.12% | — | -15.05% | |
| 5 | ✓ | Orchard Therapeutics PLC | Stock-Other | 5.56% | — | +1529.62% | |
| 6 | LRMR | Larimar Therapeutics INC | Stock-Other | 5.35% | — | — | |
| 7 | KROS | Keros Therapeutics INC | Stock-Other | 5.15% | — | +1.37% | |
| 8 | ✓ | Ikena Oncology INC | Stock-Other | 3.74% | — | +2.78% | |
| 9 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 3.04% | — | +152.94% | |
| 10 | CMPX | Compass Therapeutics INC | Stock-Other | 2.21% | — | — | |
| 11 | MLYS | Mineralys Therapeutics INC | Stock-Other | 2.14% | — | — | |
| 12 | ✓ | Inozyme Pharma INC | Stock-Other | 2.11% | — | +6.28% | |
| 13 | SYRS | Syros Pharmaceuticals INC | Stock-Other | 2.03% | — | +69.31% | |
| 14 | 2655787D | Blueprint Medicines CORP | Stock-Other | 1.85% | — | — | |
| 15 | LABDUSD | Drx Dly S&p Biotech Bear 3x | ETF-Tech | 1.84% | — | -30.77% | |
| 16 | TSVT* | 2seventy Bio INC | Stock-Other | 1.56% | — | +17.61% | |
| 17 | MLTX | Moonlake Immunotherapeutics | Stock-Other | 1.36% | — | — | |
| 18 | OVID | Ovid Therapeutics INC | Stock-Other | 1.32% | — | — | |
| 19 | SGMT | Sagimet Biosciences Inc-a | Stock-Other | 1.22% | — | — | |
| 20 | OHI | Omega Healthcare Investors, Inc. | Stock-Real Estate | 0.90% | — | — | |
| 21 | BDTX | Black Diamond Therapeutics I | Stock-Other | 0.82% | — | -4.00% | |
| 22 | ✓ | Rallybio CORP | Stock-Other | 0.52% | — | -28.01% | |
| 23 | IRON | Disc Medicine INC | Stock-Other | 0.47% | — | -80.02% | |
| 24 | GRPH | Graphite Bio INC | Stock-Other | 0.23% | — | — | |
| 25 | ✓ | Stock-Other | 0.15% | — | +299.95% | ||
| 26 | ✓ | Stock-Other | 0.08% | — | -62.17% |
Reported value over time
Sector allocation
Sector allocation over time
Quarterly history
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2023-09-30 | 28 | $252.3M | 0 | |
| 2023-06-30 | 26 | $329.6M | 0 | |
| 2023-03-31 | 24 | $376.7M | 0 | |
| 2022-12-31 | 23 | $375.5M | 0 | |
| 2022-09-30 | 25 | $371.9M | 0 | |
| 2022-06-30 | 28 | $261.8M | 0 | |
| 2022-03-31 | 22 | $235.2M | 0 | |
| 2021-12-31 | 20 | $301.3M | 0 | |
| 2021-09-30 | 19 | $342.6M | 0 | |
| 2021-06-30 | 18 | $429.9M | 100 | |
| 2021-03-31 | 21 | $499.5M | 70 | |
| 2020-12-31 | 23 | $355.0M | 32 | |
| 2020-09-30 | 22 | $281.1M | 35 | |
| 2020-06-30 | 19 | $256.3M | 100 | |
| 2020-03-31 | 13 | $42.4M | 100 | |
| 2019-12-31 | 12 | $132.6M | 29 | |
| 2019-09-30 | 13 | $102.7M | 0 |
Holding changes this quarter
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|
FAQ
What is CHI Advisors LLC and what type of investor is it?
CHI Advisors LLC is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2023-09-30), the firm manages a tracked equity portfolio valued at approximately $252.3M, spread across 28 disclosed positions.
What are CHI Advisors LLC's largest equity positions?
Based on the latest 13F filing, CHI Advisors LLC's top holdings by market value are:
1. Pliant Therapeutics INC (PLRX) — $52.3M (20.7%)
2. Repare Therapeutics INC (RPTX) — $36.0M (14.3%)
3. Cullinan Therapeutics INC (CGEM) — $30.9M (12.3%)
4. Acelyrin INC — $23.0M (9.1%)
5. Orchard Therapeutics PLC — $14.0M (5.6%)
What changes did CHI Advisors LLC make in its most recent portfolio filing?
No notable portfolio changes were recorded for CHI Advisors LLC in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does CHI Advisors LLC focus on?
CHI Advisors LLC is concentrated in the following sectors based on its current disclosed equity portfolio:
• Real Estate: 100.0%